Maymona Abdelmagid

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

Naseema Gangat, Omer Karrar, Moazah Iftikhar et al. · American Journal of Hematology · 2023 · 75 citations · Full text

Medicine, Hematology, Oncology +13

Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases

Kaaren K. Reichard, Ayalew Tefferi, Maymona Abdelmagid et al. · Blood Cancer Journal · 2022 · 40 citations · Full text

Medicine, Hematology, Oncology +17

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent

Naseema Gangat, Azeem Elbeih, Nour Ghosoun et al. · American Journal of Hematology · 2024 · 29 citations · Full text

Medicine, Hematology, Oncology +17

<scp><i>TP53</i></scp> Mutations in Myeloproliferative Neoplasms: Context‐Dependent Evaluation of Prognostic Relevance

Ayalew Tefferi, Maymona Abdelmagid, Giuseppe Gaetano Loscocco et al. · American Journal of Hematology · 2025 · 21 citations · Full text

Medicine, Hematology, Oncology +13

BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia

Ayalew Tefferi, Saubia Fathima, Maymona Abdelmagid et al. · Blood · 2025 · 21 citations · Full text

Medicine, Hematology, Oncology +17